OAM
XENE icon

Oxford Asset Management’s Xenon Pharmaceuticals XENE Stock Holding History

Oxford Asset Management’s Portfolio XENE Stock Details XENE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$400K Sell
6,884
-495
-7% -$22.8K 0.17% 184
2025
Q4 		$331K Sell
7,379
-14,783
-67% -$621K 0.12% 268
2025
Q3 		$890K Buy
22,162
+1,024
+5% +$36.1K 0.3% 87
2025
Q2 		$662K Buy
21,138
+14,964
+242% +$488K 0.22% 134
2025
Q1 		$207K Buy
+6,174
New +$234K 0.09% 349
2020
Q1 		– Sell
-12,553
Closed -$165K – 1340
2019
Q4 		$165K Buy
+12,553
New +$132K ﹤0.01% 1575

Other funds holding XENE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $22.9B AUM 115.26% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return